Literature DB >> 3032796

Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans.

K T Miyasaki, J J Zambon, C A Jones, M E Wilson.   

Abstract

The binding of the neutrophil enzyme myeloperoxidase (MPO) to microbial surfaces is believed to be the first step in its microbicidal activity. The MPO-H2O2-Cl- system is responsible for most oxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils. There appear to be three forms of MPO (MPO I, II, and III), all of which can kill this organism in the presence of H2O2 and chloride. In this study, we characterized the binding of native human neutrophil MPO to A. actinomycetemcomitans by an elution procedure dependent on the cationic detergent cetyltrimethylammonium bromide. Binding of native MPO was rapid and reached apparent equilibrium within 1 min. A proportion of binding under equilibrium conditions was saturable and highly avid, with a capacity of 4,500 sites per cell and a dissociation constant of 7.9 X 10(-10) M. At equal protein concentrations, more MPO III bound than MPO II, and more MPO II bound than MPO I. The high-avidity interaction was inhibitable with yeast mannan and with the serotype-defining mannan of A. actinomycetemcomitans. Binding was also partially reversible with yeast mannan. MPO bound to the high-avidity sites did not oxidize guaiacol but oxidized chloride, as detected by the chlorination of taurine. MPO bound to the high-avidity sites was incapable of killing A. actinomycetemcomitans alone in the presence of H2O2 and Cl-, but potentiated killing when sufficient additional MPO was provided. The killing of A. actinomycetemcomitans by the MPO-H2O2-Cl- system was inhibited by yeast mannan and a serotype-defining mannan of A. actinomycetemcomitans. We conclude that high-avidity binding of MPO to the surface of A. actinomycetemcomitans is a mannan-specific interaction and that MPO bound to the high-avidity sites is essential but not alone sufficient to kill A. actinomycetemcomitans.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032796      PMCID: PMC260463          DOI: 10.1128/iai.55.5.1029-1036.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Collagenolytic activity associated with Bacteroides species and Actinobacillus actinomycetemcomitans.

Authors:  P B Robertson; M Lantz; P T Marucha; K S Kornman; C L Trummel; S C Holt
Journal:  J Periodontal Res       Date:  1982-05       Impact factor: 4.419

2.  Identification of tissue-invading bacteria in human periodontal disease.

Authors:  F R Saglie; F A Carranza; M G Newman; L Cheng; K J Lewin
Journal:  J Periodontal Res       Date:  1982-09       Impact factor: 4.419

3.  Purification and characterization of the serotype c antigen from Actinobacillus actinomycetemcomitans.

Authors:  J J Zambon; J Slots; K Miyasaki; R Linzer; R Cohen; M Levine; R J Genco
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

4.  Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein.

Authors:  H Odeberg; I Olsson
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

5.  Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system.

Authors:  K T Miyasaki; M E Wilson; R J Genco
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

6.  Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline.

Authors:  J Slots; B G Rosling
Journal:  J Clin Periodontol       Date:  1983-09       Impact factor: 8.728

7.  Arming of mononuclear phagocytes by eosinophil peroxidase bound to Staphylococcus aureus.

Authors:  P G Ramsey; T Martin; E Chi; S J Klebanoff
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.

Authors:  C C Tsai; B J Shenker; J M DiRienzo; D Malamud; N S Taichman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Multiple forms of myeloperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity, and subunit structure.

Authors:  S O Pember; R Shapira; J M Kinkade
Journal:  Arch Biochem Biophys       Date:  1983-03       Impact factor: 4.013

View more
  12 in total

1.  In vitro and in vivo activities of E-101 solution against Acinetobacter baumannii isolates from U.S. military personnel.

Authors:  G A Denys; J C Davis; P D O'Hanley; J T Stephens
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

Review 2.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

3.  Five-year longitudinal assessment (2008 to 2012) of E-101 solution activity against clinical target and antimicrobial-resistant pathogens.

Authors:  Gerald A Denys; Chris M Pillar; Daniel F Sahm; Peter O'Hanley; Jackson T Stephens
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

Review 4.  What really happens in the neutrophil phagosome?

Authors:  James K Hurst
Journal:  Free Radic Biol Med       Date:  2012-05-15       Impact factor: 7.376

Review 5.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

6.  Characterization of bovine neutrophil antibacterial polypeptides which bind to Escherichia coli.

Authors:  L Litteri; D Romeo
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

7.  Comparative study of HOCl-inflicted damage to bacterial DNA ex vivo and within cells.

Authors:  Christine Suquet; Jeffrey J Warren; Nimulrith Seth; James K Hurst
Journal:  Arch Biochem Biophys       Date:  2009-10-20       Impact factor: 4.013

8.  Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention.

Authors:  Michael J Davies
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

9.  Different behavior of myeloperoxidase in two rodent amoebic liver abscess models.

Authors:  Andrea Cruz-Baquero; Luz María Cárdenas Jaramillo; Manuel Gutiérrez-Meza; Rosa Adriana Jarillo-Luna; Rafael Campos-Rodríguez; Víctor Rivera-Aguilar; Angel Miliar-García; Judith Pacheco-Yepez
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

10.  Myeloperoxidase modulates human platelet aggregation via actin cytoskeleton reorganization and store-operated calcium entry.

Authors:  Irina V Gorudko; Alexey V Sokolov; Ekaterina V Shamova; Natalia A Grudinina; Elizaveta S Drozd; Ludmila M Shishlo; Daria V Grigorieva; Sergey B Bushuk; Boris A Bushuk; Sergey A Chizhik; Sergey N Cherenkevich; Vadim B Vasilyev; Oleg M Panasenko
Journal:  Biol Open       Date:  2013-07-26       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.